Amdocs (DOX) Margin Stability Faces Scrutiny As EPS Softens In Q2 2026

Amdocs Limited

Amdocs Limited

DOX

0.00

Amdocs (DOX) Q2 2026 earnings: steady top line, softer EPS, and a margins story investors will focus on

Amdocs (DOX) has reported Q2 2026 revenue of US$1,172 million and basic EPS of US$1.29, with the stock trading around US$61.29 as investors weigh the latest set of numbers. The company has seen quarterly revenue move from US$1,110 million in Q1 2025 to US$1,172 million in Q2 2026, while basic EPS has ranged from US$1.34 to US$1.46 in early 2025 to US$1.29 this quarter, setting a clear track record for you to benchmark against the trailing twelve month EPS of US$5.02. With net profit margin nudging higher over the last year, this earnings print keeps the focus squarely on how durable those margins and cash generation look from here.

See our full analysis for Amdocs.

With the headline figures on the table, the next step is to see how these results line up with the widely held narratives around Amdocs's growth, risks, and valuation, and where the numbers start to challenge those stories.

NasdaqGS:DOX Revenue & Expenses Breakdown as at May 2026
NasdaqGS:DOX Revenue & Expenses Breakdown as at May 2026

Margins and profit: 11.8% net margin under the microscope

  • On a trailing basis, Amdocs reports net income (excluding extra items) of US$545.8 million on US$4.6b of revenue, which works out to an 11.8% net margin compared with 11.4% a year earlier.
  • Consensus narrative highlights multi year cloud and AI projects as a key support for margins, and this is being tested against relatively modest trailing profit growth of 0.3% per year and a five year earnings decline of about 3.6% per year, so investors will want to see whether the current 11.8% margin reflects early benefits from higher value SaaS and AI contracts or is still largely driven by traditional managed services.

Top line steady, EPS choppy across recent quarters

  • Quarterly revenue has moved in a narrow band, from US$1,110.1 million in Q1 2025 to US$1,172.0 million in Q2 2026, while quarterly basic EPS over the same stretch has ranged from US$0.88 in Q4 2025 up to US$1.46 in Q1 2025 before landing at US$1.29 this quarter.
  • Bulls argue that cloud and generative AI offerings will support higher operating margins in the long run, yet the recent EPS swing from US$0.88 to US$1.46 and then to US$1.29 shows earnings still move around from quarter to quarter. This means the bullish margin story is playing out against a backdrop where revenue is relatively stable but profit per share is more volatile than the multi year growth narratives might suggest.
    • For example, Q2 2025 and Q2 2026 both show revenue in the US$1.1b range, yet net income excluding extra items moved from US$160.2 million to US$135.0 million, which is a meaningful difference for any thesis that assumes steadily rising profitability.
    • At the same time, the trailing twelve month EPS of US$5.02 sits between the more optimistic long term earnings projections and the softer recent quarterly prints, so readers can use it as a reference point when weighing how quickly those projections might need to materialize.
Consistent earnings growth is central to the optimistic view that AI and cloud projects will reshape profitability, so it is worth stress testing that story against the mixed quarterly EPS pattern and what it might mean for how smooth that path could be over time. 🐂 Amdocs Bull Case

Valuation gap: P/E of 12.2x versus DCF fair value of US$152.51

  • The stock trades around US$61.29 with a trailing P/E of roughly 12.2x, compared with peer averages of 13.1x and a US IT industry P/E of 20.5x, while a DCF fair value of US$152.51 in the dataset sits well above the current share price.
  • Bears point out that five year earnings have declined about 3.6% per year and revenue growth is forecast at just 3.9% per year, so the current discount to peers and to the DCF fair value can be read as the market asking for proof that earnings growth closer to the forecast 13.6% per year is achievable rather than simply assuming the stock should rerate toward the analyst consensus target of US$81.21 or toward the modelled DCF value.
    • Critics highlight that, even with an 11.8% net margin and a 3.66% dividend yield, the longer term decline in earnings over five years sits awkwardly next to any narrative that expects the valuation gap to close quickly without sustained improvement in reported profit.
    • On the other hand, the combination of a single digit revenue growth outlook and low teens forecast earnings growth implies an increased reliance on margin expansion. This is exactly where the cautious narrative focuses its concerns about how much more efficiency can realistically be extracted from a telecom heavy customer base.
Skeptics often view the wide spread between today’s 12.2x P/E and the implied upside to DCF fair value as a signal to scrutinize the slower five year earnings trend and the 3.9% revenue growth forecast even more closely before assuming the discount will close. 🐻 Amdocs Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Amdocs on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With the mixed messages from margins, EPS and valuation, sentiment around Amdocs is clearly split, so it makes sense to move fast and test the numbers yourself. To understand why some investors are still optimistic, take a closer look at the 4 key rewards

See What Else Is Out There

The recent five year earnings decline, uneven quarterly EPS and reliance on margin expansion indicate that Amdocs is not offering the smooth profit story some investors might prefer.

If you want ideas where the growth thesis already looks more aligned with today’s numbers, start comparing opportunities in the 46 high quality undervalued stocks

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.